2496 — Wuhan YZY Biopharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.45bn
- HK$1.33bn
Annual cashflow statement for Wuhan YZY Biopharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -149 | -189 | -192 |
| Depreciation | |||
| Non-Cash Items | 53.8 | 3.15 | 1.72 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -11.5 | 2.12 | -3.31 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -98.7 | -177 | -186 |
| Capital Expenditures | -1.9 | -1.41 | -1.93 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -18 | 7.21 | 56.7 |
| Sale of Fixed Assets | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -19.9 | 5.8 | 54.8 |
| Financing Cash Flow Items | -4.39 | -6.73 | -9.88 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 81 | 241 | 176 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -37.6 | 70.4 | 43.2 |